CHAPTER 19 PARACETAMOL + IBUPROFEN

Similar documents
Simultaneous HPLC Determination of Methocarbamol, Paracetamol and Diclofenac Sodium

Impact factor: 3.958/ICV: 4.10 ISSN:

Volume 6, Issue 2, January February 2011; Article-015

DEVELOPMENT AND VALIDATION OF A RP-HPLC METHOD FOR DETERMINATION OF LOPINAVIR IN BULK AND PHARMACEUTICAL DOSAGE FORM

Validated RP-HPLC Method for Estimation of Cefprozil in Tablet Dosage Form

International Journal of Pharmacy and Pharmaceutical Sciences Vol 2, Issue 1, 2010

4.1 MATERIALS 4.2 EQUIPMENTS

SIMULTANEOUS RP HPLC DETERMINATION OF CAMYLOFIN DIHYDROCHLORIDE AND PARACETAMOL IN PHARMACEUTICAL PREPARATIONS.

Research Article. Simultaneous spectrophotometric estimation of Paracetamol and Aceclofenac by second order derivative method in combined dosage form

INTERNATIONAL JOURNAL OF UNIVERSAL PHARMACY AND BIO SCIENCES

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD TO DETERMINE CINITAPRIDE HYDROGEN TARTARATE IN BULK AND PHARMACEUTICAL FORMULATION

CHAPTER V ANALYTICAL METHODS ESTIMATION OF DICLOFENAC. Diclofenac (gift sample from M/s Micro Labs Ltd., Pondicherry)

Zero And First Order Derivative Spectrophotometric Methods For Determination Of Dronedarone In Pharmaceutical Formulation

Received: ; Accepted:

7. Stability indicating analytical method development and validation of Ramipril and Amlodipine in capsule dosage form by HPLC.

Stability Indicating RP-HPLC Method for Determination of Valsartan in Pure and Pharmaceutical Formulation

International Journal of Pharma and Bio Sciences V1(1)2010. HPLC method for analysis of Lercanidipine Hydrochloride in Tablets

Stability indicating RP-HPLC method for determination of azilsartan medoxomil in bulk and its dosage form

SIMULTANEOUS ESTIMATION OF MEFENAMIC ACID AND PARACETAMOL IN SUSPENSION FORM BY USING UPLC

Pelagia Research Library

Research Article METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF ELBASVIR AND GRAZOPREVIR BY RP-HPLC

A RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF PARA- PHENYLENEDIAMINE IN PURE FORM AND IN MARKETED PRODUCTS

Development and validation a RP-HPLC method: Application for the quantitative determination of quetiapine fumarate from marketed bulk tablets

Journal of Chemical and Pharmaceutical Research, 2014, 6(7): Research Article

Chapter-4 EXPERIMENTAL WORK BY RP-HPLC

UV Spectrophotometric Method Development and Validation of Ezetimibe and Simvastatin in Bulk and Pharmaceutical Dosage Form

Asian Journal of Research in Chemistry and Pharmaceutical Sciences Journal home page:

USP Method Transfer and Routine Use Analysis of Irbesartan Tablets from HPLC to UPLC

Reverse Phase High Performance Liquid Chromatography method for determination of Lercanidipine hydrochloride in bulk and tablet dosage form

Development of Validated Analytical Method of Mefenamic Acid in an Emulgel (Topical Formulation)

Available Online through

UV Spectrophotometric Estimation of Levoceterizine Dihydrochloride in Bulk and Dosage Form

RP-HPLC Method for the Estimation of Nebivolol in Tablet Dosage Form

Analytical Method Development and Validation of Lafutidine in Tablet dosage form by RP-HPLC

Analytical method development and validation of gabapentin in bulk and tablet dosage form by using UV spectroscopic method

AREA UNDER CURVE AND SECOND ORDER DERIVATIVE SPECTROSCOPY OF METAXALONE IN BULK DRUG AND TABLET FORMULATION

Development and Validation of UV Spectrophotometric Estimation of Diclofenac Sodium Bulk and Tablet Dosage form using Area under Curve Method

Journal of Chemical and Pharmaceutical Research

J Pharm Sci Bioscientific Res (4): ISSN NO

Simultaneous Estimation Of Paracetamol And Pamabrom Inbulk Drugs And In Pharmaceutical Formulation By Spectrophotometry

Spectroscopic Method For Estimation of Atorvastatin Calcium in Tablet Dosage Form

Research Article. Figure 1. Chemical structure of doxofylline. Indonesian J. Pharm. Vol. 24 No. 1 : ISSN-p :

Development and Statistical Validation of Spectrophotometric Methods for the Estimation of Nabumetone in Tablet Dosage Form

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

Liquid Chromatography and Spectroscopic Method for Estimation of Sulphadoxine in Marketed Formulation

CHAPTER - 3 ANALYTICAL PROFILE. 3.1 Estimation of Drug in Pharmaceutical Formulation Estimation of Drugs

VALIDATION STUDY OF THE HPLC ASSAY OF SOME ANTIAMOEBIC AGENTS

DEVELOPMENT AND VALIDATION OF A SPECTROPHOTOMETRIC METHOD FOR DETERMINATION OF DRONEDARONE IN BULK DRUG AND PHARMACEUTICAL FORMULATION

Development and Validation of Stability Indicating RP-HPLC Method for the Determination of Anagrelide HCl in Pharmaceutical Formulation

A NEW HPLC METHOD FOR THE QUANTIFICATION OF PANTOPRAZOLE IN PHARMACEUTICALS

RP-HPLC Method Development and Validation of Dapagliflozin in Bulk and Tablet formulation

ANALYTICAL METHOD PROCEDURES

INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND LIFE SCIENCES

International Journal of PharmTech Research CODEN (USA): IJPRIF, ISSN: , ISSN(Online): Vol.9, No.7, pp , 2016

RP-HPLC Estimation of Trospium Chloride in Tablet Dosage Forms

Revision Bulletin 27 Jan Feb 2017 Non-Botanical Dietary Supplements Compliance

Development and Validation of Stability Indicating Assay Method of Etodolac by using UV-Visible Spectrophotometer

Revision Bulletin 29 Dec Jan 2018 Non-Botanical Dietary Supplements Compliance

New Simple UV Spectrophotometric Method for Determination of Mirtazapine in Bulk and pharmaceutical dosage forms

RP-HPLC Method for Simultaneous Estimation of Atenolol, Hydrochlorothiazide and Losarton in Tablet Dosage form

International Journal of Pharma Research and Health Sciences. Available online at

STABILITY INDICATING RP HPLC METHOD FOR ANALYSIS OF DORZOLAMIDE HCl IN THE BULK DRUG AND IT S PHARMACEUTICAL DOSAGE FORM

Department of Quality Assurance, Luqman College of Pharmacy, GULBARGA (K.S.) INDIA ABSTRACT

New Spectrophotometric Multicomponent Estimation of Ciprofloxacin and Tinidazole Tablets

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF IVABRADINE HCL IN BULK AND FORMULATION

A Reverse Phase Liquid Chromatography Analysis of Citicoline Sodium in Pharmaceutical Dosage Form using Internal Standard Method

Development and Validation of a HPLC Method for Determination of Anastrozole in Tablet Dosage Form

Method development and validation for the estimation of metronidazole in tablet dosage form by UV spectroscopy and derivative spectroscopy

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

of nm throughout the experimental work.

Journal of Pharmaceutical and Biomedical Analysis Letters. Analysis Letters

Chapter 4: Verification of compendial methods

NEVIRAPINE ORAL SUSPENSION Final text for addition to The International Pharmacopoeia (February 2009)

Int. J. Pharm. Sci. Rev. Res., 30(2), January February 2015; Article No. 09, Pages: 63-68

Validated First Order Derivative Spectroscopic Method for the determination of Stavudine in Bulk and Pharmaceutical Dosage Forms

Validated spectrophotometric determination of Fenofibrate in formulation

Research Article Spectrophotometric Estimation of Didanosine in Bulk Drug and its Formulation

Spectrophotometric estimation and validation of hydrochlorothiazide in tablet dosage forms by using different solvents

INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES

Stability-indicating HPLC determination of tolterodine tartrate in pharmaceutical dosage form

Journal of Chemical and Pharmaceutical Research, 2012, 4(6): Research Article. Estimation of zaleplon by a new RP-HPLC method

DETERMINATION OF DRUG RELEASE DURING DISSOLUTION OF NICORANDIL IN TABLET DOSAGE FORM BY USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

SIMULTANEOUS ESTIMATION OF CILOSTAZOL AND ASPIRIN IN SYNTHETIC MIXTURE USING HPTLC METHOD

Simultaneous estimation of meclizine and nicotinic acid by using RP-HPLC

TruptiS.Bobade*, Madhuri D. Game and Pawan P. Iche. Vidyabharti College of Pharmacy, C.K. Naidu road, Camp, Amravati ,MH,India.

Received: ; Accepted:

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS OF GABAPENTIN IN PURE AND PHARMACEUTICAL FORMULATIONS

RP - HPLC METHOD FOR ESTIMATION OF PARACETAMOL FROM PHARMACEUTICAL FORMULATION FEBRINIL

Intrinsic Stability analysis and Assay Method for Determination of Fenofibrate in formulation by HPLC

Development and Validation of Stability-Indicating RP-HPLC Method for Estimation of Atovaquone

Novus International Journal of Analytical Innovations 2012, Vol. 1, No. 3

Simultaneous Estimation of Metolazone and Spironolactone in Combined Tablet Dosage Form BY UV Spectroscopy.

DEVELOPMENT AND VALIDATION OF A HPLC METHOD FOR IN-VIVO STUDY OF DICLOFENAC POTASSIUM

A novel approach to the analysis of multivitamin by online supercritical fluid extraction/supercritical fluid chromatography

Simultaneous Estimation Of Montelukast Sodium And Desloratadine By RP-HPLC In Their Marketed Formulation

Determination of Caffeine by HPLC

Validated RP-HPLC Method for the Quantitation of Benfotiamine in Bulk and Tablet Dosage Form

RESEARCH ARTICLE ANALYTICAL METHOD DEVELOPMENT OF TOLPERISONE HYDROCHLORIDE IN TABLET DOSAGE FORM BY UV VISIBLE SPECTROPHOTOMETRY.

KEYWORDS: Acetaminophen, Doxylamine succinate, Dextromethorphan hydrobromide.

Simultaneous estimation of ramipril and valsartan by RP-HPLC method in combined. dosage form

Transcription:

CHAPTER 19 PARACETAMOL + IBUPROFEN

SUMMARY 246 A combination of paracetamol and ibuprofen is marketed in India. Literature survey indicated that one titrimetnc-1-** and one HPLC193 methods are reported for this combination. The HPLC method reported involves diode array detection. A new HPLC method was developed for the simultaneous determination of paracetamol and ibuprofen in combined dosage forms. A Phenomenex ODS column and a mobile phase consisting of methanolwater-acetic acid (80 : 20 : 1) were utilized. The flow rate used was 1.5 ml/min. UV detection at 235 nm was carried out. The retention times of paracetamol and ibuprofen were 2.3 and 6.4 min. respectively. The sensitivity ranges were 0.43-4.33 mcg/ml of paracetamol and 15.02-120.16 mcg/ml of ibuprofen. The new HPLC method was utilized for the assay of commercial tablets and suspension containing the two drugs. Precision and recovery studies were also carried out. The method is simple, rapid and precise.

EXPERIMENTAL Chemicals Used : Paracetamol was supplied by SIGMA Chemical Company, St. Louis, U.S.A. Ibuprofen was a gift sample provided by the Central Indian Pharmacopoeia Laboratory, Ghaziabad. Methanol and Acetic Acid (HPLC grade) were supplied by Spectrochem Pvt. Ltd., Bombay, India. Double distilled water was used for the HPLC studies. Ingtruroentatibn : The chromatographic system consisted of a ERC-8710 pump (Erma Optical Works, Japan), a degasser (model : ERC-3310) with a variable wavelength UV detector and a Chromatocorder 11 Integrator (Alphatech Corporation Ltd., Japan). A Phenomenex ODS (5/i) column (250 mm x 4.6 mm i.d.) was utilized. All spectrophotometric measurements were made using a Shimadzu spectrophotometer (model : UV-260). All weighings were performed on a Sartorius single pan balance. The mobile phase was methanol-water-acetic acid (80 : 20 : 1), filtered through a 0.45 m membrane filter and pumped at a flow rate of 1.5 ml/min. (pressure = 2800 p.s.i.). The UV detector was operated at 235 nm at a sensitivity of 0.005 A.U.F.S. The attenuation and chart speed of the integrator were set at 512 and 5 mm/min. respectively. Preparation of standard curves : Paracetamol : A stock solution (86.5 mcg/ml) of the drug in methanol was first prepared. From the stock solution, various concentrations were prepared ranging from 0.4325-4.3250 mcg/ml. Hundred microliters of each sample was injected three

times and the mean peak heights were utilized for linear regression analysis. Ibuprofen : A stock solution (300.4 mcg/ml) of the drug in methanol was first prepared. From the stock solution, various concentrations were prepared ranging from 15.02-120.16 mcg/ml. Hundred microliters of each sample was injected three times and the mean peak heights were utilized for linear regression analysis. The results obtained are presented in Tables 75, 76 and Figures 47 and 48. Sample Preparation : 1) Tablets : Twenty tablets were weighed and powdered. A quantity of the powder equivalent to 5 mg of ibuprofen was taken, dissolved in 10 ml of the mobile phase and filtered through Whatman No.44. The filtrate was diluted with the mobile phase to provide an approximate concentration of 50 mcg/ml of ibuprofen (Sample 1). Hundred microliters of this sample was injected three times and the mean peak height was utilized for the calculation of the concentration of ibuprofen from the regression equation. Sample 1 was further diluted with the mobile phase to provide an approximate concentration of 2 mcg/ml of paracetamol (Sample 2). Hundred microliters of Sample 2 was injected 3 times and the mean peak height was utilized for the calculation of paracetamol concentration from the regression equation. 2) Suspension : A volume equivalent to 5 mg of ibuprofen was diluted to 5 ml with methanol and filtered through Whatman No.44 filter paper. It was further diluted to provide two solutions as described under tablets.

249 TABLE 75 : STANDARD CURVE FOR PARACETAMOL No. Concentration mcg/ml Mean Peak Height*, cm. SD CV(%) 1 0.4325 1.0333 0.06 5.59 2 0.8650 2.1333 0.06 2.71 3 1.7300 4.2667 0.06 1.35 4 2.1625 5.3000 0.10 1.89 5 3.0275 7.4333 0.06 0.78 6 4.3250 10.2333 0.15 1.49 *=Mean of 3 readings LINEAR REGRESSION ANALYSIS RESULTS Peak Height = 2.3740 x Concentration + 0.1041 n = 6( r = 0.9995

250 STANDARD CURVE FOR PARACETAMOL FIGURE 47 CONCENTRATION (megm) (mb) IKOflH XV3d NV3H

251 TABLE 76 : STANDARD CURVE FOR IBUPROFEN No. Concentration mcg/ml Mean Peak Height*, cm. SD CV(%) 1 15.02 1.2000 0.10 8.33 2 30.04 2.4333 0.06 2.37 3 45.06 3.6333 0.06 1.59 4 75.10 6.0667 0.06 0.95 5 105.14 8.5333 0.06 0.68 6 120.16 9.7333 0.06 0.59 *=Mean of 3 readings LINEAR REGRESSION ANALYSIS RESULTS Peak Height = 0.0812 x Concentration - 0.0178 n = 6, r = 0.999995

252 STANDARD CURVE FOR IBUPROFEN 0 20 40 60 SO 100 120 F IG U R E 48 CONCENTRATION (mca/ml) («U9) 1H0I3H XV3d NV3H

253 RESULTS AND DISCUSSION The proposed assay method uses a mobile phase comprising of methanol - water - acetic acid in the ratio 80 : 20 : 1 (v/v) which gives a good resolution between paracetamol and ibuprofen. The addition of acetic acid in the mobile phase helps in improving the peak shape. Thus the mobile phase preparation in the proposed method is easy a«td also economic as it does not employ any costly solvents. The chromatogram obtained is shown in Figure 49. The retention times of paracetamol and ibuprofen were 2.3 and 6.4 min. respectively. The standard curves were linear over the entire concentration ranges of the two drugs (r = 0.9995 for paracetamol and r = 0.999995 for ibuprofen ). Precision studies were performed by injecting 1.73 mcg/ml of paracetamol and 75.1 mcg/ml of ibuprofen, six times. The coefficients of variation (CV) obtained were 1.21% and 1.24% respectively for the two drugs. Recovery studies were performed by taking known amounts of the two drugs and analyzing them by the proposed HPLC technique. Each sample was injected three times and the mean peak height was utilized for the recovery study. The results obtained are presented in Tables 77 and 78. Few market samples were analyzed by the proposed method. The results obtained are presented in Table 79. A high attenuation (512) was chosen in order to minimize the dilutions. The sensitivity can be further increased by decreasing the attenuation. The precision of the proposed method is good and

254 FIGURE 49 1 1 = Paracetamol (2.2 min.) 2 = Ibuprofen (6.4 min.)

255 TABLE 77 : RECOVERY OF PARACETAMOL NO. Amount Taken mcg/ml Amount Found mcg/ml % Recovery 1 0.4325 0.4336 100.2 2 0.8650 0.8548 98.8 3 1.7300 1.7253 99.7 4 2.1625 2.1747 100.6 5 3.0275 3.0312 100.1 6 4.3250 4.2949 99.3 Mean = 99.8 SD =0.66 CV(%) = 0.66

TABLE 78 : RECOVERY OF IBUPROFEN No. Amount Taken mcg/ml Amount Found mcg/ml % Recovery 1 15.0200 14.9991 99.9 2 30.0400 29.7791 99.1 3 45.0600 44.5590 98.9 4 75.1000 74.1188 98.7 5 105.1400 104.9104 99.8 6 120.1600 120.9220 100.6 Mean =99.5 SD = 0.73 CV(%) 0.73

257 TABLE 79 : ANALYSIS OF COMMERCIAL DOSAGE FORMS NO. Dosage Form Labelled Amount of paracetamol %Label Claim Labelled Amount of ibuprofen %Label Claim 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Tablet 500 mg 93.7 400 mg 97.1 -do- 97.3 -do- 98.1 400 mg 96.1 -do- 103.3 333 mg 97.3 -do- 95.0 325 mg 98.6 -do- 90.9 -do- 103.1 -do- 97.1 -do- 101.9 -do- 105.4 -do- 94.9 -do- 99.2 -do- 91.4 -do- 97.1 -do- 101.9 -do- 100.2 -do- 97.3 -do- 95.0 -do- 99.6 -do- 96.1 -do- 100.8 -do- 99.2 -do- 99.6 -do- 94.0 -do- 99.6 200 mg 96.2 Suspension 162.5 mg/5 ml 102.4 100 mg/5 ml 95.0 125 mg/5 ml 102.7 -do- 101.2

258 an internal standard is therefore not very essential. The proposed method is simple, specific and accurate and can be conveniently adopted for the routine analysis of paracetamol and ibuprofen in combined dosage forms. =====*=====*=====